An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats

Journal of Neuro-Oncology

Volumn 74, Issue 1, 2005, Pages 9-17

  Zhu, Xinmei ^a   Lu, Chuanzhen ^a   Xiao, Baoguo ^a   Qiao, Jian ^a   Sun, Yi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Dendritic cell; Glioma; Immunotherapy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DRUG PULSE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; FOLLOW UP; GLIOMA; GLIOMA CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; RAT; STEREOTAXIS; SURVIVAL RATE; T LYMPHOCYTE; TUMOR VOLUME;

ANIMALS; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIOMA; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-10; RATS; RATS, WISTAR;

EID: 23944508839     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-3339-x     Document Type: Article

References (43)

1. TS Surawicz F Davis S. Freels 1998 Brain tumor survival: Results from the National Cancer Data Base J Neurooncol 40 151-160 10.1023/ A:1006091608586 9892097
2. KL Black K Chen DP Becker 1992 Inflammatory leukocytes associated with increased immunosuppression by glioblastoma J Neurosurg 77 120-126 1318961
3. MS Mahaley WH Brooks TL Roszman et al. 1997 Immunobiology of primary intracranial tumors J Neurosurg 46 467-472
4. M Maxwell T Galanopoulos J Neville-Golden et al. 1998 Effect of the expression of transforming growth factor-beta 2 in primary human glioblastomas on immunosuppression and loss of immune surveillance J Neurosurg 76 799-804
5. JP Zou LA Morford C Chougnet et al. 1999 Human glioma-induced suppression involves soluble factor(s) that alter monocyte cytokine profile and surface markers J Immunol 162 4882-4892 10202033
6. Ashley David M. Faiola Brenda Nair Smita et al. 1997 Dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors J Exp Med 186 1177-1182 10.1084/ jem.186.7.1177 9314567
7. JI Mayordomo T Zorina WJ Storkus et al. 1995 Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nature Med 1 1297-1302 10.1038/ nm1295-1297 7489412
8. L Zitvogel JI Mayordomo T Tjandrawan et al. 1996 Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 183 87-97 10.1084/jem.183.1.87 8551248
9. H Okada H Tahara M Shurin et al. 1998 Bone marrow derived dendritic cells pulsed with a tumor specific peptide elicit effective anti-tumor immunity against intracranial neoplasms Int J Cancer 78 196-201 10.1002/ (SICI)1097-0215(19981005)78:2<196::AID-IJC13>3.0.CO;2-9 9754652
10. TK Hoffmann N Meidenbauer G Dworacki et al. 2000 Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells Cancer Res 60 3542-3549 10910067
11. MV Dhodapkar RM Steinman J. Krasovsky et al. 1999 Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells J Clin Invest 104 173-80 10411546
12. ML Albert SF Pearce LM Francisco et al. 1998 Immature dendritic cells phagocytose apoptotic cells via v 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes J Exp Med 188 1359-1368 10.1084/ jem.188.7.1359 9763615
13. S Gallucci M Lolkema P Matzinger 1999 Natural adjuvants: Endogenous activators of dendritic cells Nature Med 5 1249-1255 10.1038/15200 10545990
14. Max Schnurr Scholz Christoph Rothenfusser Simon et al. 2002 Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and γδ T cells Cancer Res 62 2347-2352 11956095
15. G Multhoff C Botzler L Jennen et al. 1997 Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells J Immunol 158 4341-4350 9126997
16. SR Scheffer H Nave F Korangy et al. 2003 Apoptotic, but not necrotic, tumor cell vaccine induce a potent immune response in vivo Int J Cancer 103 205-211 10.1002/ijc.10777 12455034
17. ML Albert SJ Pearce LM Francisco et al. 1999 Immature dendritic cells phagocytose apoptotic cells viaαVβ5 and CD86, and cross-present antigens to cytotoxic T lymphocytes J Exp Med 188 7 1359-1368 10.1084/jem.188.7.1359
18. K Inaba M Inaba N Romani et al. 1992 Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J Exp Med 176 1693-1702 10.1084/jem.176.6.1693 1460426
19. A Porgador E Gilboa 1995 Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes J Exp Med 182 255-260 10.1084/jem.182.1.255 7540653
20. DL Peterson PJ Sheridan WE Brown Jr et al. 1994 Animal model for brain tumors: Historical perspectives and future directions J Neurosurg 80 865-876 8169627
21. P Brossart S Wirths W Brugger et al. 2001 Dendritic cells in cancer vaccines Exp Hematol 29 1247-1255 10.1016/S0301-472X(01)00730-5 11698120
22. LM Liau KL Black RM Prins et al. 1999 Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens J Neurosurg 90 1115-1124 10350260
23. WE Carson JG Jakowat R Yamamoto et al. 1991 Rat mitogen-stimulated lymphokine-activated T killer cells: Production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats J Immunother 10 131-140 2043593
24. CA Kruse MC Molleston EP Parks et al. 1994 A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: A comparison to 9L gliosarcoma J Neuro-oncol 22 191-200 10.1007/BF01052919
25. M Resnicoff C Sell M Rubini et al. 1994 Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors Cancer Res 54 2218-2222 8174129
26. M Resnicoff J Tjuvajev HL Rotman et al. 1996 Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA J Exp Ther Oncol 1 385-389 9414429
27. F San-Galli P Vrignaud J Robert et al. 1989 Assessment of the experimental model of transplanted C6 glioblastoma in Wistar rats J Neurooncol 7 299-304 10.1007/BF00172924 2795124
28. AS Beutler MS Banck D Wedekind et al. 1999 Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model Hum Gene Ther 10 1 95-101 10.1089/10430349950019228 10022534
29. AT Parsa I Chakrabarti P Hurley et al. 2000 Limitations of the C6/Wistar Rat Intracerebral Glioma Model: Implications for evaluating for immunotherapy Neurosurgery 47 993-1000 10.1097/00006123-200010000-00050 11014444
30. TF Witham ML Erff H Okada et al. 2002 7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provide an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model Neurosurg 50 6 1327-1335 10.1097/00006123-200206000-00025
31. SK Nair D Snyder BT Rouse et al. 1997 Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts Int J Cancer 70 6 706-715 10.1002/ (SICI)1097-0215(19970317)70:6<706::AID-IJC13>3.0.CO;2-7 9096653
32. JH Sampson GE Archer DM Ashley et al. 1996 Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8 + T cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system Proc Natl Acad Sci USA 93 10399-10404 10.1073/pnas.93.19.10399 8816812
33. U Herrlinger CM Kramm KM Johnston et al. 2997 Vaccination for experimental gliomas using granulocyte-macrophage colony-stimulating factor-transduced tumor cells Cancer Gene Ther 4 345-352
34. GM Bundy RE Merchant 1996 Lymphocyte trafficking to the central nervous system: A review of anatomic, immunologic, and molecular mechanisms Neurosurgery Quarterly 6 51-68
35. HF Cserr PM Knopf 1992 Cervical lymphatics, the blood-brain barrier, and the immunoreactivity of the brain: A new view Immunol Today 13 507-512 10.1016/0167-5699(92)90027-5 1463583
36. H Neumann H Wekerle 1998 Neuronal control of the immune response in the central nervous system: Linking brain immunity to neurodegeneration J Neuropathol Exp Neurol 57 1-9 9600191
37. PJ Gebicke-Haerter 2001 Microglia in neurodegeneration: Molecular aspects Microsc Res Tech 54 47-58 10.1002/jemt.1120 11526957
38. G Raivich M Bohatschek CU Kloss et al. 1999 Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function Brain Res Rev 30 77-105 10.1016/ S0165-0173(99)00007-7 10407127
39. MR Waal de H Yssel MG Roncarolo et al. 1992 Interleukin-10 Curr Opin Immunol 4 314-320 10.1016/0952-7915(92)90082-P 1418711
40. J Kim RL Modlin RL Moy et al. 1995 IL-10 production in cutaneous basal and squamous cell carcinomas: A mechanism for evading the local T cell immune response J Immunol 155 2240-2247 7636270
41. P Pisa E Halapi EK Pisa et al. 1992 Selective expression of interleukin 10, interferon-gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies Proc Natl Acad Sci USA 89 7708-7712 1502188
42. T Suzuki H Tahara S Narula et al. 1995 Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors J Exp Med 182 477-486 10.1084/ jem.182.2.477 7629507
43. S Todryk AA Melcher N Hardwick et al. 1999 Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake J Immunol 163 3 1398-408 10415040